Influence of the endothelium and nitric oxide on the contractile responses evoked by 5-HT(1D) receptor agonists in the rabbit isolated saphenous vein

British Journal of Pharmacology

Volumn 119, Issue 1, 1996, Pages 35-42

  Valentin, Jean Pierre ^a   Bonnafous, Régine ^a   John, Gareth W ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

5 carboxamidotryptamine; 5 HT(1D) receptor; 5 hydroxytryptamine; Nitric oxide; Rabbit saphenous vein; Sumatriptan

Indexed keywords

5 CARBAMOYLTRYPTAMINE; ENDOTHELIUM DERIVED RELAXING FACTOR; IDAZOXAN; INDOMETACIN; KETANSERIN; METHYLENE BLUE; METITEPINE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PRAZOSIN; SEROTONIN; SEROTONIN 1 AGONIST; SEROTONIN 1D ANTAGONIST; SEROTONIN 1D RECEPTOR; SUMATRIPTAN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SAPHENOUS VEIN; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

EID: 0029835115     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15674.x     Document Type: Article

References (25)

1. ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother., 14, 48-58.
2. 1D antagonists. J. Med. Chem., 37, 2253-2257.
3. 1D receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 352, (Suppl. 1) R15.
4. FENIUK, W., HUMPHREY, P.P.A., PERREN, M.J. & WATTS, A.D. (1985). A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor subtypes obtained by use of selective agonists and antagonists. Br. J. Pharmacol., 86, 697-704.
5. FERRARI, M.D. & SAXENA, P.R. (1993). Clinical and experimental effects of sumatriptan in humans. Trends Pharmacol. Sci., 14, 129-133.
6. GLUSA, E. & MÜLLER-SCHWEINITZER, E. (1993). Heterogeneity of 5-HT receptor subtypes in isolated human femoral and saphenous veins. Naunyn-Schmiedeberg's Arch. Pharmacol., 347, 133-136.
7. HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, P.R. & HUMPHREY, P.P.A. (1994). International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46, 157-203.
8. HUMPHREY, P.P.A. & FENIUK, W. (1991). Mode of action of the anti-migraine drug sumatriptan. Trends Pharmacol. Sci., 12, 444-446.
9. 1like receptor in dog isolated saphenous vein. Br. J. Pharmacol., 94, 1123-1132.
10. 1 receptor-mediated vasoconstriction in bovine isolated pulmonary arteries: influences of vascular endothelium and tone. Pulm. Pharmacol., 7, 65-72.
11. MARQUARDT, D.W. (1963). An algorithm for least squares estimation of nonlinear parameters. J. Soc. Indust. Appl. Math., 11, 431.
12. MARTIN, G.R. & MACLENNAN, S.J. (1990). Analysis of the 5-HT receptor in rabbit saphenous vein exemplifies the problems of using exclusion criteria for receptor classification. Naunyn-Schmiedeberg's Arch. Pharmacol., 342, 111-119.
13. MCCULLOCH, K.M., TEMPLETON, A.G. & MACLEAN, M.R. (1994). Effect of nitric oxide synthase inhibitor on contractile responses to sumatriptan in bovine pulmonary arteries. Thorax, 49, 426P.
14. 1-like receptor mediated responses in dog saphenous vein. Naunyn-Schmiedeberg's Arch. Pharmacol., 347, 257-265.
15. MONCADA, S. & HIGGS, A. (1993). The L-arginine-nitric oxide pathway. New Engl. J. Med., 329, 2002-2012.
16. PALMER, R.M., ASHTON, D.S. & MONCADA, S. (1988). Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature, 333, 664-666.
17. 1Dα receptor sites. Neuropharmacology, 34, 235-237.
18. RAZZAQUE, Z., LONGMORE, J. & HILL, R.G. (1995). Differences in the effects of ketanserin and GR127935 on 5-HT-receptor mediated responses in rabbit saphenous vein and guinea-pig jugular vein. Eur. J. Pharmacol., 283, 199-206.
19. SCHOEFFTER, P., ULLMER, C., GUTIERREZ, M., WEITZ-SCHMIDT, G. & LUBBERT, H. (1995). Functional serotonin 5-HT receptors and 5-HT receptor mRNA expression in human umbilical vein endothelial cells. Naunyn-Schmiedeberg's Arch. Pharmacol., 352, 580-582.
20. 1D receptor antagonist. Br. J. Pharmacol., 110, 9P.
21. SUBCUTANEOUS SUMATRIPTAN INTERNATIONAL STUDY GROUP (1991). Treatment of migraine attacks with sumatriptan. N. Engl. J. Med., 325, 316-321.
22. SWEENEY, G., TEMPLETON, A., CLAYTON, R.A., BAIRD, M., SHERIDAN, S., JOHNSTON, E.D. & MACLEAN, M.R. (1995). Contractile responses to sumatriptan in isolated bovine pulmonary artery rings: relationship to tone and cyclic nucleotide levels. J. Cardiovasc. Pharmacol., 26, 751-760.
23. 1,-like receptors mediate contractions of the rabbit saphenous vein. Eur. J. Pharmacol., 191, 375-382.
24. 1β receptors. Eur. J. Pharmacol., 287, 79-84.
25. 1-like receptors by endogenous nitric oxide. Br. J. Pharmacol., 114, 969-974.